Quantum-Si (QSI) Net Income towards Common Stockholders (2020 - 2026)
Quantum-Si (QSI) posted quarterly Net Income towards Common Stockholders of -$21.7 million for Q1 2026, down 12.93% year-over-year from -$24.9 million in Q1 2025, and down 23.05% quarter-over-quarter from -$17.6 million in Q4 2025.
Quantum-Si (QSI) Net Income towards Common Stockholders (2020 - 2026) Analysis & Trends
Quantum-Si (QSI) has reported Net Income towards Common Stockholders for 7 consecutive years, with -$21.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Net Income towards Common Stockholders fell 12.93% year-over-year to -$21.7 million; the TTM figure through Mar 2026 stood at -$103.8 million (down 3.08% YoY), while the FY2025 annual figure was -$101.3 million, changed 0.33% from the prior year.
- Net Income towards Common Stockholders declined to -$21.7 million in Q1 2026 per QSI's latest filing, from -$17.6 million in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at -$17.6 million in Q4 2025 and bottomed at -$35.7 million in Q3 2025.
- Historically, Net Income towards Common Stockholders has averaged -$26.6 million across 5 years, with a median of -$25.3 million in 2024.
- Annual changes were most pronounced in 2022 — Net Income towards Common Stockholders slumped 198.62% — and 2025, when it jumped 46.83%.
- Quantum-Si's Net Income towards Common Stockholders stood at -$33.1 million in 2022, then surged by 33.47% to -$22.0 million in 2023, then tumbled by 50.22% to -$33.1 million in 2024, then soared by 46.83% to -$17.6 million in 2025, then slipped by 23.05% to -$21.7 million in 2026.
- Business Quant data shows QSI's Net Income towards Common Stockholders at -$21.7 million in Q1 2026, -$17.6 million in Q4 2025, and -$35.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 907.00 Mn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | 621.86 Mn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Quantum-Si | 174.11 Mn | 174.11 Mn | 172,000.00 | -23.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -23.53 Mn |
| Mar 31, 2026 | -21.67 Mn |
| Dec 31, 2025 | -17.61 Mn |
| Sep 30, 2025 | -35.70 Mn |
| Jun 30, 2025 | -28.84 Mn |
| Mar 31, 2025 | -19.19 Mn |
| Dec 31, 2024 | -33.12 Mn |
| Sep 30, 2024 | -25.31 Mn |
| Jun 30, 2024 | -23.10 Mn |
| Mar 31, 2024 | -19.47 Mn |
| Dec 31, 2023 | -22.05 Mn |
| Sep 30, 2023 | -24.73 Mn |
| Jun 30, 2023 | -25.57 Mn |
| Mar 31, 2023 | -23.61 Mn |
| Dec 31, 2022 | -33.14 Mn |
| Sep 30, 2022 | -31.71 Mn |
| Jun 30, 2022 | -32.41 Mn |
| Mar 31, 2022 | -35.18 Mn |
| Dec 31, 2021 | -29.42 Mn |
| Sep 30, 2021 | -18.09 Mn |